China Universal Asset Management Co., Ltd. Vaxcyte, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 21,466 shares of PCVX stock, worth $1.94 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
21,466
Previous 12,781
67.95%
Holding current value
$1.94 Million
Previous $965,000
153.89%
% of portfolio
0.27%
Previous 0.14%
Shares
14 transactions
Others Institutions Holding PCVX
# of Institutions
354Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.03 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$988 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$899 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$786 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$443 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.36B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...